Table 1.
Study period | ||||||||
---|---|---|---|---|---|---|---|---|
Enrollment | Allocation | Post allocation | Closeout | |||||
Time point | −T1 | T0 | T1 | T2 | T3 | T4 | T5 | T6 |
Enrollment | ||||||||
Eligibility screen | X | |||||||
Informed consent | X | |||||||
Allocation | X | |||||||
Interventions | X | X | X | X | X | X | X | |
Assessments | ||||||||
Major cardiovascular events | X | X | X | X | X | X | ||
Health behaviors | ||||||||
Smoking status | X | X | X | X | X | X | X | |
Dietary intake | X | X | X | X | X | X | X | |
Physical activity | X | X | X | X | X | X | X | |
Medication adherence | X | X | X | X | X | X | X | |
Anthropometry parameters | ||||||||
Weight | X | X | X | X | X | X | X | |
Body mass index | X | X | X | X | X | X | X | |
Waist circumference | X | X | X | X | X | X | X | |
Biochemical parameters | ||||||||
Total cholesterol | X | X | X | X | X | X | ||
Low-density lipoprotein cholesterol | X | X | X | X | X | X | ||
High-density lipoprotein cholesterol | X | X | X | X | X | X | ||
Fasting blood glucose | X | X | X | X | X | X | ||
Hemoglobin A1c | X | X | X | X | X | X | ||
Systolic blood pressure | X | X | X | X | X | X | ||
Diastolic blood pressure | X | X | X | X | X | X | ||
10-year Framingham risk scores of cardiovascular risks | X | X | X | X | X | X | ||
All-cause mortality | X | X | X | X | X | X | ||
All-cause readmission | X | X | X | X | X | X | ||
Frequency of medical treatment due to CHD | X | X | X | X | X | X | ||
Patients’ engagement in the intervention | X | X | X | X | X | X | ||
Mediators and moderators of behavior changea | ||||||||
Risk perception | X | X | X | X | X | |||
Outcome expectation | X | X | X | X | X | |||
Action planning | X | X | X | X | X | |||
Coping planning | X | X | X | X | X | |||
Behavioral enjoyment | X | X | X | X | X | |||
Social support | X | X | X | X | X | |||
Self-efficacy | X | X | X | X | X | |||
Effectiveness perception | X | X | X | X | X | |||
Intention | X | X | X | X | X | |||
Motivation | X | X | X | X | X | |||
Volition | X | X | X | X | X | |||
Stages of behavior changea | X | X | X | X | X | |||
Knowledge of CHD | X | X | X | X | X | |||
Perceived importance of health behaviors | X | X | X | X | X |
CHD, coronary heart disease. −T1: Start point for patient recruitment; T0: Baseline; T1: 1 month; T2: 3 months; T3: 6 months; T4: 12 months; T5: 24 months; T6: 36 months
aThe stages of behavior change, mediators and moderators of behavior change will be assessed dynamically